Kanghong Pharmaceutical announced that Compassic eye injections were included in category B of the “National Catalogue of Drugs for Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance”. This drug is limited to wet age-related macular degeneration, vision impairment due to diabetic macular edema, vision impairment due to choroidal neovascularization, and vision damage caused by macular edema secondary to retinal vein occlusion. The new version of the “Medical Insurance Drug Catalogue” will be implemented on January 1, 2026.

Zhitongcaijing · 2d ago
Kanghong Pharmaceutical announced that Compassic eye injections were included in category B of the “National Catalogue of Drugs for Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance”. This drug is limited to wet age-related macular degeneration, vision impairment due to diabetic macular edema, vision impairment due to choroidal neovascularization, and vision damage caused by macular edema secondary to retinal vein occlusion. The new version of the “Medical Insurance Drug Catalogue” will be implemented on January 1, 2026.